Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials.

Christina BaechleWiebke ScherlerAlexander LangTim FillaOliver Kuss

Published in: Acta diabetologica (2022)

Based on the results of more than 200 randomized trials, HbA1c is not a valid surrogate marker for all-cause mortality in people with type 2 diabetes.

Keyphrases

type diabetes
cardiovascular events
glycemic control
cardiovascular disease
risk factors
insulin resistance
metabolic syndrome
skeletal muscle